A detailed history of Ruffer LLP transactions in United Therapeutics Corp stock. As of the latest transaction made, Ruffer LLP holds 10,763 shares of UTHR stock, worth $3.2 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
10,763
Previous 14,374 25.12%
Holding current value
$3.2 Million
Previous $4.43 Million 30.22%
% of portfolio
0.16%
Previous 0.17%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 16, 2025

SELL
$276.47 - $328.4 $998,333 - $1.19 Million
-3,611 Reduced 25.12%
10,763 $3.09 Million
Q1 2025

May 09, 2025

BUY
$304.42 - $380.78 $890,428 - $1.11 Million
2,925 Added 25.55%
14,374 $4.43 Million
Q4 2024

Feb 07, 2025

BUY
$348.66 - $410.0 $3.99 Million - $4.69 Million
11,449 New
11,449 $4.04 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $13.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Ruffer LLP Portfolio

Follow Ruffer LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ruffer LLP, based on Form 13F filings with the SEC.

News

Stay updated on Ruffer LLP with notifications on news.